Mayme Lou Roettig was appointed Senior Vice President at Baim Institute for Clinical Research in August 2023 after serving as a strategic consultant for the Institute and Dr Gibson since December 2022. She is responsible for overseeing strategic initiatives and generating new research and education business while supporting the CEO and faculty in new business activities. She has worked with Dr. Gibson for over 30 years in education, clinical development and outcomes research.

Ms. Roettig has been a leader and change agent bringing evidence-based research into practice to impact patient outcomes. Ms. Roettig held clinical nurse positions in large U.S. medical centers in coronary and critical care units, medical telemetry units, and interventional cardiac catheterization labs. In addition, she served as an advanced practice nurse in cardiology clinics. Trained as a cardiovascular clinical nurse specialist, Ms. Roettig has spent most of her career in research and education. Her research career spans working in early phase to large phase 3 clinical development trials to focusing on outcomes research. Specifically, she focused on quality initiatives and implementation science to improve process and clinical outcomes for the cardiovascular patient.

Prior to joining Baim, Ms. Roettig worked in multiple leadership roles within Biotechnology Genentech, Inc. Cardiovascular franchise during the fibrinolysis era for Myocardial Infarction and Acute Ischemic Stroke from 1996-2004. Ms. Roettig was instrumental as a pioneer in some of the early ST Elevation Myocardial Infarction quality improvement and systems of care work that changed how the U.S. healthcare system responded to patients experiencing acute coronary syndrome symptoms. Ms. Roettig worked for the Duke Clinical Research Institute, Duke University in various leadership roles from 2005-2019, including: Executive Director of the RACE Campaigns in ST Elevation Myocardial Infarction and Cardiac Arrest, Assistant Director for the Center of Educational Excellence developing the Accelerator and IMPACT AF studies, and as the Operations Director of Health Systems and Implementation Science in Health Services Research initiating the IMPROVE Stroke Care and COORDINATE Diabetes studies. Ms. Roettig served as the National Director for the American Heart Association for their flagship STEMI Mission: Lifeline Initiative as staff spokeswoman. She also worked alongside the volunteer leadership teams at AHA to improve emergency response in ST-Elevation Myocardial Infarction from 2008-2010 and has continued as a volunteer leader.